DENNIS VINIAS: Open Payments
NPI 1912275926 · WESTMINSTER, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,058 in 56 payments from 10 companies in 2025. Trend: 2023 $1,064 · 2024 $1,003 · 2025 $1,058
Food & beverage: $1,058
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $215 |
| AstraZeneca Pharmaceuticals LP | 8 | $174 |
| Novo Nordisk Inc | 8 | $158 |
| ABBVIE INC. | 11 | $148 |
| Lilly USA, LLC | 5 | $87 |
| Exact Sciences Corporation | 3 | $73 |
| Axsome Therapeutics, Inc. | 3 | $68 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $50 |
| Amgen Inc. | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
Products named: NURTEC ODT, UBRELVY, BREZTRI, MOUNJARO, Auvelity, Ozempic, AIRSUPRA, Rybelsus.
Industry payments across MD — which companies pay providers there.
